LIGAND PHARMACEUTICALS INCORPORATED
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $476.4M | $1.30B | $19.5M |
| FY2022 | $165.2M | $762.7M | $45.0M |
| FY2023 | $86.3M | $787.2M | $23.0M |
| FY2024 | $111.3M | $941.8M | $72.3M |
| FY2025 | $543.4M | $1.56B | $174.9M |